Bluebird Bio reported $-3.43 in EPS Earnings Per Share for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acceleron Pharma XLRN:US -1.05 0
Agios Pharmaceuticals AGIO:US -1.44 28.39
Alexion Pharmaceuticals ALXN:US $ 3.52 0.56
Alnylam Pharmaceuticals ALNY:US $ -1.61 0.1
Amgen AMGN:US $ 4.38 0.68
Applied Genetic Technologies AGTC:US -0.28 0.12
Arrowhead Research ARWR:US -0.29 0.03
Avrobio Inc AVRO:US -0.74 0.09
Biogen BIIB:US $ 4.77 0.91
Biomarin Pharmaceutical BMRN:US $ 0.07 0.02
Bluebird Bio BLUE:US $ -3.43 0.36
Dicerna Pharmaceuticals DRNA:US -0.53 0.14
Gilead Sciences GILD:US $ 1.87 0.21
Immunogen IMGN:US -0.15 0.02
Intercept Pharmaceuticals ICPT:US $ -0.33 0.89
IONIS PHARMACEUT IONS:US $ -0.57 0.07
Mirati Therapeutics MRTX:US -3.23 0.56
Moderna Inc MRNA:US 6.46 3.62
Nektar Therapeutics NKTR:US $ -0.69 0.02
Novartis NOVN:VX SF 1.66 0.14
Pfizer PFE:US $ 1.07 0.14
Ptc Therapeutics PTCT:US $ -1.68 0.15
Regeneron Pharmaceuticals REGN:US $ 25.8 15.91
Sangamo Biosciences SGMO:US $ -0.33 0.01
Sarepta Therapeutics SRPT:US -2.3 0.2
Seattle Genetics SGEN:US $ -0.47 0.2
Ultragenyx Pharmaceutical RARE:US $ -1.81 0.22
Vertex Pharmaceuticals VRTX:US $ 3.11 0.13
YTE INCY:US $ 0.8 0.13